| Previous Close | 21.84 |
| Open | 22.01 |
| Bid | 21.90 x 100 |
| Ask | 24.99 x 100 |
| Day's Range | 21.85 - 22.59 |
| 52 Week Range | 7.20 - 27.09 |
| Volume | 685,019 |
| Avg. Volume | 1,006,382 |
| Market Cap | 964.91M |
| Beta | 4.00 |
| PE Ratio (TTM) | -14.98 |
| EPS (TTM) | -1.47 |
| Earnings Date | Aug 7, 2017 - Aug 11, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 36.40 |
- Accesswire•7 days ago
Today's Research Reports on Stocks to Watch: Sorrento Therapeutics and Omeros Corporation
NEW YORK, NY / ACCESSWIRE / July 17, 2017 / Sorrento Therapeutics had a big insider purchase revealed last week that helped drive share prices higher. Omeros Corporation also saw big gains after announcing ...
- MarketWatch•11 days ago
Technical trading: These four stocks are breaking out of their pattern
Bluebird bio, Omeros and two other companies are showing strong momentum.
- American City Business Journals•17 days ago
Omeros threatens to sue anonymous detractor
Omeros Corp. said it plans legal action against an an anonymous detractor claiming to be a shareholder of the Seattle-based biotech company. Omeros said it doesn't typically respond to defamatory statements, but did so this case due to the egregious nature of the allegations. "This report is replete with falsehoods, misleading statements and incorrect analyses and conclusions," Omeros said in a news release .
